ArticleHealth science reports2024

Metabolic Outcomes of Changing From Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine to Rilpivirine/Tenofovir Alafenamide/Emtricitabine: A Longitudinal Study.

Ping-Feng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.